Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeli...
Hallux Valgus, also know as Bunion, is the most common forefoot problem in adults. It is the most common pathologic entity of the big toe. It refers to the progressive swelling of the soft tissue. Hallux valgus has been reported to affect approximately 23% of the adult population aged 18 to 65 years global...
Find More
Bristol Myers' Experimental Psoriasis drug succeeds in late-stage study defeats rival Amgen's Otezla Bristol Myers' experimental psoriasis drug, deucravacitinib has outmarched Amgen's Otezla (apremilast) in the POETYK PSO-1 Phase III clinical trial in patients with moderate to severe plaque psoriasis. Deucravaci...
Find More
Epidermolysis bullosa (EB) places a significant socioeconomic burden on patients. Several reports stated that Epidermolysis bullosa had a considerable negative impact on the quality of the lives of patients. Although it is a rare disease, EB is a cause of significant morbidity and mortality among the affected indiv...
Find More
The current Rosacea Pipeline therapies include FMX103 (Foamix Pharmaceuticals), Epsolay (Sol-Gel Technologies), ACU-D1 (Accuitis), HY01 (Hovione Scientia Limited), AFX4031 (Afecta Pharmaceuticals), AOB103 (AOBiome), and others. The therapies intend to address the unmet needs in the Rosacea treatment market. Awa...
Find More
Incyte meets endpoint in the second pivotal atopic dermatitis clinical trial A second phase 3 trial of Incyte’s ruxolitinib cream in atopic dermatitis has hit its primary endpoint. The back-to-back pivotal successes irked Incyte to talk to regulators regarding upcoming of the JAK inhibitor to market. Ruxoliti...
Find More
The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain. The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee unanimously has decided not to recommend the use of the painkiller, ta...
Find More
Eczema is an umbrella term comprising skin disorders characterised by dry, discoloured, itchy and inflamed skin. Hand eczema (HE) are non-infectious, inflammatory cutaneous lesions and belongs to the most common skin disorder affecting the hands. In a substantial number of patients, HE can develop into a chronic...
Find More
Dupilumab, a monoclonal antibody, is administered in the form of injection for the treatment of Atopic dermatitis (Eczema) in adults and children of age 12 and old. The injection works by hampering the substance in the body, which produces allergic reactions. Dupilumab is a receptor-antagonist and binds to the alph...
Find More
Atopic dermatitis, also known as atopic eczema, is a condition that results in itchy, scaly and red skin. It is an inflammatory skin disease which is a common recurrent form of skin allergy. Acute flare-ups of eczematous pruritic lesions mainly categorise atopic dermatitis over dry skin due to high levels ...
Find More
Pyelonephritis (Kidney infection) is an infection of the kidney, which is a consequence of urinary t.....
Find More
The pharma industry has played a crucial role in fighting against the pandemic situation by supplyin.....
Find More
The first biosimilar was made available to patients in the United States six years ago in 2021. Thes.....
Find More
Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from .....
Find More
The coronavirus outbreak has affected thousands of people in at least 186 countries which has also a.....
Find More
Axial Spondyloarthritis (axSpA) is an umbrella term for a form of inflammatory form of arthritis ass.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
